Delivery Order SPE2DR25D9628-SPE2DR26FBTLE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,462.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TICOVAC 1.2MCG/0.25 1S vaccine supply. Issued on December 17, 2025, with an ultimate completion date of January 15, 2026, this firm fixed-price delivery order carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $6,326.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TICOVAC 2.4 MCG/0.5 vaccine product. The delivery order, issued on October 23, 2025, with an ultimate completion date of November 6, 2025, was structured as a firm fixed-price contract with no set-aside designation, allowing the vendor to compete on equal...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TICOVAC 1.2MCG/0.25 vaccine. The contract was awarded on January 14, 2026, with a firm fixed-price structure and no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,261.86 for TICOVAC 2.4MCG/.5ML vaccine by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge facility. The award represents a single delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TICOVAC 2.4MCG/0.5 vaccine units. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,890.54 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2MCG/0.25 1S, a vaccine product. The award, issued on October 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, leveraging the company's established capacity as a critical pharmaceutical supplier. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park...
- The Defense Logistics Agency issued a $1,680.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TICOVAC 1.2MCG/0.25 1S vaccine. The award, issued on November 5, 2025, represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain program, awarded a firm fixed-price delivery order valued at $2,851.32 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2MCG/0.25 1S vaccine supply. The award, issued on August 4, 2025, with an ultimate completion date of the same day, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,658.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TICOVAC 1.2MCG/0.25 1S vaccine product. The delivery order, issued on November 5, 2025, with an ultimate completion date of the same day, is structured as a firm fixed-price contract with no set-aside designation, indicating the vendor competed on an unrestricted basis. The award represents...
- The Defense Logistics Agency awarded a $2,134.57 firm fixed-price delivery order (4570007403) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TICOVAC 2.4MCG/0.5 10S vaccine product. The award, finalized on November 14, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery...
- SPE2DR25D9628Indefinite Delivery Contract
- SPE2DR25D9628-SPE2DR26FBTLEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,675.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TICOVAC 2.4MCG/0.5 10S vaccine products. The award, issued on January 15, 2026, with an ultimate completion date of January 29, 2026, carries firm fixed-price pricing and was made without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure comprehensive pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a single-award IDC under the PPV-G GEN V program with a $499.999 billion ceiling value and a completion date of December 31, 2036. The company's extensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with demonstrated performance across multiple therapeutic categories. The contractor operates with no identified subcontractors and maintains consistent contract performance across numerous delivery orders from the DLA Medical Supply Chain division, positioning it as a key regional prime vendor contractor supporting the Department of Defense's global medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 1/14/26 |